begin testing human coronavirus vaccine

The volunteers will be people who have not tested positive for the COVID-19 coronavirus. Nor can pregnant women be part of the test

On Thursday they will begin testing a human coronavirus vaccine developed by the University of Oxford. The British Government will provide £ 20 million to the university team and a further £ 22.5 million to Imperial College.

The Oxford scientists indicated that the goal is to produce one million doses of the vaccine so that they are in circulation since September.

Katrina Pollock, principal investigator of these trials at Imperial College London, stated in the press that “progress is being made very rapidly and there may be some answers as to how” these vaccines are performing for the fall (of the northern hemisphere) ” , that is to say for September.

Meanwhile, he said that the development of the vaccine began last January, when scientists were able to sequence the virus in China: “From that moment on, the work to create a vaccine progressed at great speed,” he said.

In late March, Adrian Hill, director of the Jenner Institute at Oxford University, said: “The vaccines are being designed from scratch and are progressing at an unprecedented rate. The next trial will be critical to assess the feasibility of vaccination against COVID. -19 and could lead to an early deployment. “

Health authorities have carried out 18,206 tests in 24 hours and have detected 4,301 new confirmed cases of the disease, of which 129,044 people have already been infected in the country since the pandemic began.

Regarding the ability to produce the vaccine and its distribution, the scientist said from the United Kingdom that they will be informed when the first doses are available.

Find out the latest on digital economy, startups, fintech, corporate innovation and blockchain. CLICK HERE